Figure 6.
Downregulation of CXCL17 production in IL-4-stimulated normal human epidermal keratinocytes (NHEK) and decreased CXCL17 expression in patients with atopic dermatitis (AD). Expression of CXCL17 mRNA was assessed in NHEK cells treated with IL-4 stimulation. CXCL17 expression levels were evaluated in sera of patients with AD. (A) CXCL17 mRNA expression by NHEK was significantly attenuated by IL-4 stimulation. (B) Serum levels of CXCL17 in patients with AD were significantly decreased compared with normal controls. * p < 0.05.